Journal of Neuroscience, Vol 4, 966-977, Copyright © 1984 by Society for Neuroscience
Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites
A Imperato and G Di Chiara
A method for the estimation in rats of the in vivo release and metabolism
of dopamine (DA) is described. The method is based on the dialysis
principle and consists of inserting transversally in the striatum a thin
(0.2 mm) dialysis tube (Amicon Vitafiber) which is then perfused with
Ringer. The Ringer, flowing at a constant rate of 2 microliters/min in the
dialysis tube, extracts low molecular weight substances from the
surrounding tissue by way of simple diffusion along a concentration
gradient. At the distal end of the dialysis tube, the Ringer is collected
every 10 to 20 min and directly injected into a high performance liquid
chromatographer (HPLC) equipped with reverse phase octadecyl sulfate
columns which separate DA and its metabolites, dihydroxyphenylacetic acid
(DOPAC) and homovanillic acid (HVA). These substances are then
quantitatively estimated by oxidative electrochemical detection. The basal
output of DA is 0.3 pmol/20 min, whereas the outputs of DOPAC and HVA are
60 and 20 pmol/20 min, respectively. In basal conditions the output of DA,
DOPAC, and HVA is stable over at least 10 hr. Histological examination of
the track left by the dialysis probe in rats after 10 hr of continuous
dialysis reveals very little damage and normal neuronal morphology in the
vicinity of the dialysis tube. Increase of the K+ concentration in the
Ringer to 30 mM produced a sharp, reversible increase of DA output. Both
the basal and K+-stimulated release were Ca++ dependent, because omission
of Ca++ abolished basal and K+-stimulated DA release. Electrical
stimulation of the nigrostriatal DA neurons in the medial forebrain bundle
sharply increased DA output. Amphetamine sulfate in low doses (1.0 mg/kg,
i.v.) produced a 9-fold increase in DA release and decreased DOPAC and HVA
output. alpha-Methyl tyrosine (150 mg/kg, i.v.) reduced within 2 hr DA
release to 15% of basal values and in parallel also decreased the output of
DOPAC and HVA. Reserpine (5 mg/kg, i.p.) reduced DA release but in a slower
fashion than alpha- methyl tyrosine and increased DOPAC and HVA. Pargyline
(75 mg/kg, i.p.) produced a 4-fold increase of DA release, while it rapidly
brought to zero DOPAC and HVA output. gamma-Butyrolactone (700 mg/kg, i.p.)
rapidly and lastingly reduced DA, DOPAC, and HVA output. The biochemical
and histological results obtained indicate that the method is suitable to
estimate in the rat the changes in the release o f endogenous DA and its
metabolites which take place in vivo under administration of centrally
acting drug.